Skip to contentSkip to sidebarSkip to footer
Complete Omics
  • Home
  • Platforms
    • â–ş 2 Platforms
    • Complete360® | The World’s Most Comprehensive Blood Test- Simultaneously Quantifying 14,000+ BioMolecular Targets
    • Valid-NEO® | The World’s First Patented Platform for Direct Quantification of Patient-Specific Neoantigens
  • Clinical Tests
    • â–ş 4 Disease Categories
  • Research Services
    • â–ş 6 Service Programs
  • Kits
    • Target™ Kits
    • My Order
  • Company
    • Our Journey
    • Key Members
    • Selected Publications
    • Our News
    • Our Process
    • Our Old Site
  • Contact Us
0 items - $0.00 0
Complete Omics
Complete Omics
0 items - $0.00 0
Complete Omics

Blog List

Complete Omics Close
  • Home
  • Platforms
    • â–ş 2 Platforms
    • Complete360® | The World’s Most Comprehensive Blood Test- Simultaneously Quantifying 14,000+ BioMolecular Targets
    • Valid-NEO® | The World’s First Patented Platform for Direct Quantification of Patient-Specific Neoantigens
  • Clinical Tests
    • â–ş 4 Disease Categories
  • Research Services
    • â–ş 6 Service Programs
  • Kits
    • Target™ Kits
    • My Order
  • Company
    • Our Journey
    • Key Members
    • Selected Publications
    • Our News
    • Our Process
    • Our Old Site
  • Contact Us
linkedinfacebook-1twitter-xinstagram
Have a Project?
info@completeomics.com
Want to Work With Us?
Send Brief
Request a Quote?
Make One
Our News

Complete Omics Unlocks Clinical Deployment with CLIA and CAP Accreditation

Complete Omis Inc., a leader in clinical proteomics and multi-omics molecular diagnostics, today…
April 20, 2024
Our News

World-Leading VC Qiming Venture Partners Invests in Complete Omics to Accelerate Clinical Proteomics

Complete Omics Inc., a clinical proteomics and multi-omics technology company, announced the successful…
October 7, 2023
Our News

Complete Omics Founder Dr. Qing Wang Featured on Wharton Business School Website

Complete Omics Inc. is pleased to share that our founder and CEO, Dr. Qing…
June 27, 2023
Our News

Complete Omics Establishes a New Immunotherapy Target Class: HERV-Derived Neoantigens

January 29, 2022 Complete Omics Inc. announces its critical role in a landmark Science…
January 29, 2022
Our Insight Our News

A decade of Innovation in Human Plamsa-based Clinical Proteomics

May 19, 2021 Complete Omics today highlighted a decade-long scientific journey in clinical proteomics,…
May 19, 2021

Posts pagination

Page 1Page 2>
Search
Categories
  • Our Insight
  • Our News
Recent Posts
Complete Omics Unlocks Clinical Deployment with CLIA and CAP Accreditation
Our News
April 20, 2024
Complete Omics Unlocks Clinical Deployment with CLIA and CAP Accreditation
World-Leading VC Qiming Venture Partners Invests in Complete Omics to Accelerate Clinical Proteomics
Our News
October 7, 2023
World-Leading VC Qiming Venture Partners Invests in Complete Omics to Accelerate Clinical Proteomics
Tags
Office

1448 South Rolling Rd, Baltimore, MD 21227

info@completeomics.com

+1 410 215 2760
Links
  • Home
  • Platforms
  • Clinical Services
  • Research Services
  • Contact Us
Socials
  • Linkedin
  • Twitter
  • Facebook
  • Instagram
Newsletter

Complete Omics Inc. © 2026. All rights reserved.

Complete Omics
LinkedinFacebookTwitterInstagram
+1 410 215 2760
info@completeomics.com